JAMES Q. DEL ROSSO, DO, FAOCD
Dermatology, Cutaneous Surgery,
Education & Clinical Research
Las Vegas, Nevada
Email: jqdelrosso@yahoo.com
Cell Phone: 702-596-6137
Primary Contact Information
James Q. Del Rosso DO, LLC
Direct Performance of Services and/or Consultative Services in Clinical Research,
Educational Programs, and Publications in Dermatology
Over 20 years of experience nationally and internationally; has served as Principal
Investigator in multiple studies; lead author of multiple study publications.
Administrative Office and
Mailing Address:
Email:
Phone (cell):
8644 Castle Hill Avenue
Las Vegas, Nevada 89129
jqdelrosso@yahoo.com
702-596-6137
Research Center
Mailing Address:
Del Rosso Dermatology Research
8861 W. Sahara Avenue
Suite 230
Las Vegas, Nevada 89117
mj.drdr@gmail.com
702-331-4123
702-964-2425
702-596-6137
Email:
Phone (Research Center):
Phone (Melissa Jacobson, CRC)
Phone (Dr. Del Rosso)
Dermatology Private Practice
James Q. Del Rosso, DO (JDRx Dermatology, LLC)
Private Dermatology Practice
Private practice in medical dermatology (children and adults), dermatologic surgery, and Mohs
micrographic surgery. Twenty-eight years of clinical practice experience since 1986 (Ohio, 5
years; Florida, 5 years; Nevada, 19 years.
Lakes Dermatology
Clinic Address:
Phone:
8861 W Sahara Avenue
Suite 290
Las Vegas, Nevada 89117
702-869-6667 (for patient appointments only)
Dermatology Research
Page 1 of 31
Del Rosso Dermatology Research / James Q. Del Rosso, DO, LLC
Principal Investigator and Other Services in Clinical Dermatology Research
James Q. Del Rosso DO (Principal Investigator)
Over 20 years of experience in clinical research in dermatology; consultation on study design,
protocol design, data analysis, and manuscript preparation and review; investigator-initiated
studies, experience with investigator training; photographic documentation; cases study
projects. All research studies and case study/observational projects carried out in accordance
with recognized research standards, regulations, documentation, and proper informed consent.
Past study areas: acne, rosacea, eczema (including atopic dermatitis), psoriasis (topical and
systemic therapy), actinic keratosis, fungal infections, herpes zoster infection, herpes simplex
infection, seborrheic dermatitis, epidermal barrier repair.
Contact Information:
Administrative Address:
Study Site:
Melissa Jacobson CRC (Administrative Director)
mj.drdr@gmail.com; 702-964-2425
Dr. Del Rosso: jdr.drdr@gmail.com ; 702-596-6137 (cell
phone)
8644 Castle Hill Avenue
Las Vegas, Nevada 89129
Del Rosso Dermatology Research
(at Lakes Dermatology)
8861 W Sahara Avenue
Suite 230
Las Vegas, Nevada 89117
Personal Information
Born February 16, 1954 in Brooklyn, New York
Parents deceased, 1 sister (Marilyn Lanza)
Married to Karyn Del Rosso
3 children (Chrystyna, Jaclyn, Ron), 6 grandchildren (Ari, Britney, Allyson, Blake,
Emily, Asher), 2 great grandchildren (Christy Paige, Kourtney)
Hobbies: music, avid music and guitar collector, sports, avid sports collector
Educational Background
Undergraduate Education
St. John’s University College of Pharmacy
Jamaica, New York
Bachelor of Science in Pharmacy (Class of 1976)
Pharmacy Residency Education
Page 2 of 31
Temple University Hospital Department of Pharmacy
Philadelphia, Pennsylvania
Hospital Pharmacy Residency (1976-1977)
Medical School Education
Ohio University College of Osteopathic Medicine
Athens, Ohio (Class of 1982)
Graduated Cum Laude
Rotating Internship
Doctors Hospital
Columbus, Ohio (1982-1983)
Dermatology Residency and Fellowship Training
Dermatology Residency
Atlantic Skin Disease Associates/Doctors Hospital
Fort Lauderdale, Florida (1983–1986)
Program Director: David C Horowitz, DO
Mohs Micrographic Surgery and Cutaneous Oncology Fellowship
Ohio State University Arthur James Hospital
Columbus, Ohio (1990-1991)
Program Director: Ronald J Siegle, MD
Professional Employment
Current Practice Employment
Last Vegas Skin and Cancer Clinics/West Dermatology
Henderson, Nevada and Las Vegas, Nevada (1997 – current)
Past Practice Employment
Ohio University College of Osteopathic Medicine
Athens, Ohio (1986-1990)
Assistant Professor (Dermatology) in Section of Internal Medicine
Assistant Director, Medical Center Clinic
Dermatology Course Director
Page 3 of 31
West Florida Medical Center Clinic
Pensacola, Florida (1994-1996)
Dermatology, Cutaneous Surgery, and Mohs Micrographic Surgery
Director, Dermatology Laboratory/Mohs Micrographic Surgery Laboratory
Honorary Award 1994, West Florida Medical Center Academic Honor Society
Board of Directors, West Florida Medical Center Clinic
Board Certifications
Board certified in Dermatology (1988)
Certificate of Added Qualification (CAQ) in Mohs micrographic surgery (1995)
Medical Licensure
Nevada #466 (DO)
Arizona (DO)
Ohio (DO)
Since April 1989 (actively practicing in Nevada since 1996)
Since October 1996 (not actively practicing in Arizona)
Since April 1986 (original practice license, not actively
practicing in Ohio)
Academic Affiliations
Clinical Professor (Dermatology)
Adjunct Clinical Faculty
Touro University College of Osteopathic Medicine
Henderson, Nevada
(2005 – present)
Chief Instructor of Dermatology Course
Clinical Preceptor (clinic rotations for third and fourth year medical students)
Touro University College of Osteopathic Medicine
Henderson, Nevada (2005 – present)
Dermatology Residency Program Director*
Valley Hospital Medical Center
Las Vegas, Nevada
Touro University College of Osteopathic Medicine
Henderson, Nevada (2005-2013)
(*program discontinued by hospital in July 2013 due to lack of funding)
Professional Society Memberships and Activities
Memberships
Page 4 of 31
American Academy of Dermatology (AAD)
American Osteopathic College of Dermatology (AOCD)
American Acne and Rosacea Society (AARS)
American Dermatologic Association (ADA)
Council for Nail Disorders (CND)
National Society of Cutaneous Medicine (NSCM)
American Osteopathic Association (AOA)
American Society for Dermatologic Surgery (ASDS)
American College of Mohs Micrographic Surgery (ACMS)
American Society for Mohs Surgery (ASMS)
Nevada Osteopathic Medical Association (NOMA)
Dermatology Society Leadership Positions
Past-President
American Acne and Rosacea Society (2009 – 2011)
Past-President
American Osteopathic College of Dermatology (1993 - 1994)
Annual Meeting Program Chairman (1993)
Past President
Council for Nail Disorders (2006 - 2008)
Past President
American Society for Mohs Surgery (2005)
Society Board Positions
Board Member
American Osteopathic Board of Dermatology (AOBD) (1999-2010)
Reviewing and revising when warranted criteria for dermatology board certification; preparing
board certification examination; overseeing the certification process for dermatologist trained
under the American Osteopathic Association. Overall board responsibility and with
designated responsibility as co-director of section involving preparation of case study
questions with clinical photographs (visual recognition)
Board of Directors (2012-present)
National Society of Cutaneous Medicine
Board of Directors
Council for Nail Disorders (CND) (from inception through 2003)
Page 5 of 31
Board of Directors
American Acne and Rosacea Society (AARS) (2005 – 2009; 2013 - present)
Board of Directors
American Society for Mohs Surgery (ASMS) (1998 – 2005)
Society Committee Activities
Education Committee, Chairman
American Acne and Rosacea Society (AARS) (2009 – present)
Education Committee, Member
American Acne and Rosacea Society (AARS) (2007 – 2009)
Environment and Drugs Committee Chairman
American Academy of Dermatology (AAD) (2007 – 2010)
FDA Liaison Task Force
American Academy of Dermatology (2003 – 2004)
Publication Affiliations
Journal of Clinical and Aesthetic Dermatology (JCAD)
Editor-In-Chief (Clinical Dermatology) 2007 (start of journal – present)
Textbook Editor
Shalita AR, Del Rosso JQ, Webster GF. Editors, Acne Vulgaris, informaHealth, London,
UK and New York, NY, 2011
Cutis
Drug Therapy Topics Section Founder and Author
Editorial Board for peer review
Journal of Drugs in Dermatology (JDD)
Guest Editor, Annual Acne & Rosacea Issue (2007 – present)
Editorial Board for peer review
Yearbook of Dermatology and Dermatologic Surgery*
Editor (2009-2012)
(*last published in 2012, hard copy publications discontinued by publisher)
Dermatologic Clinics
Guest Editor
Page 6 of 31
Drug Actions, Reactions and Interactions (April 2007)
Antibiotic Use in Dermatology (January 2009)
Acne (in development, Guest Co-Editor)
American Acne and Rosacea Society Ad Hoc Rosacea Projects
Project Director: Guidelines on Management of Rosacea publication (2007-2008;
publication in Journal of Drugs in Dermatology)
Project Director: Understanding Pathophysiologic Mechanisms in Rosacea and
Correlation with Therapy (Meeting in Boston, MA August 2012; publication as
supplement in Cutis March 2013)
Project Director: Current Recommendations from AARS on Management of Rosacea
(5-part article series published in Cutis November 2013 – March 2014)
American Acne and Rosacea Society Pediatric Acne Ad Hoc Project
Evidence-based Recommendations for the Diagnosis and Treatment of Pediatric Acne
(meeting in 2011 followed by publication in Pediatrics in 2013; endorsed by the
American Academy of Pediatrics accepting the guidelines as their policy)
Project member: review of all section, presentation and emphasis on oral and topical
antibiotic use for acne in pediatric patients
American Acne and Rosacea Society Acne in Adult Women Ad Hoc Project
Project Director: project in progress (2014- 2015)
Dermatology Therapeutic Update: An Informational Newsletter for Pediatricians
Newsletter Editor and Co-Author (2008-2009)
Pathways: Practical Career Advice for Dermatology Residents
Newsletter Editor and Co-Author (2004 – 2008)
Extensions: An Educational Newsletter for Physician Assistants and Nurse
Practitioners in Dermatology
Newsletter Co-Editor and Co-Author (2004-2008)
Current Clinical Concepts: A Panoramic View of Literature of Significance to
Dermatology
Newsletter Co-Editor and Co-Author (2006)
National and International Dermatology Meeting Directorships and
Affiliations
International Symposium on Acne and Rosacea
Monaco, France (May 2014)
Chairman and Speaker
Page 7 of 31
Speaker: Correlation of the Pathophysiology of Rosacea with Management
Speaker: Translation of Newer Information on Pathophysiology and Inflammation with
the Optimization of Therapeutic Approaches in Acne
Moderator: Antibiotic Resistance Issue and their Relationship to the Dermatologist
Moderator: Pathophysiology of Rosacea / Rosacea Management
Moderator: Pathophysiology of Acne / Acne Management
Fall Clinical Dermatology
Las Vegas, Nevada (October 2001-present)
Program Co-Director and Speaker
Speaker: What’s New in The Medicine Chest? Part 1 and Part 2 (each year)
Advances in Onychomycosis Therapy (2013)
Scientific Poster Review (2010 – present)
Winter Clinical Dermatology
Hawaii, USA (2008-present)
Program Co-Director and Speaker
What’s New in the Medicine? Part 1 and Part 2 (each year)
Therapeutic Update (2014)
Update on Relevance of Epidermal Barrier in Health and Disease (2012)
Scientific Poster Review (2010 – present)
American Academy of Dermatology Annual Winter and Summer Meetings
Speaker and Session Director at multiple meetings (1995-present)
Acne and Rosacea Symposum (multiple years)
Controversies in Dermatology (multiple years)
Oral Isotretinoin Update (2014)
Antibiotic Use in Acne and Rosacea (multiple years)
Therapeutic Update (multiple years)
Forum on Nail Disease (2003, 2004)
Management of Onychomycosis and Cutaneous Fungal Inections (multiple years)
Update on Pathophysiology and Treatment of Rosacea (multiple years)
So Many Drugs, So Little Time (multiple years)
Drug Interactions of Significance to Dermatologists Session (multiple years)
Safety of Topical Therapies Used in Dematology (2013)
Oral Spironolactone Use in Adult Women with Acne (2013)
Topical Anti-inflammatory Therapies (2013, 2014)
Actinic Keratoses and Non-Melanoma Skin Cancers (multiple years)
Alabama Dermatology Society Seminar in the City
New York, NY (May 2014)
Speaker
Face to Face with Acne and Rosacea
Page 8 of 31
Alabama Dermatology Society Summer Seminar
San Destin, Florida (2006 - 2010, 2013 – present)
Speaker
So Many Drugs, So Little Time (multiple years)
Acne and Rosacea (multiple years)
Advances in the Management of Onychomycosis (2014)
Acne in the Adult Female (2013)
Management of Actinic Keratosis (2013)
Antibiotic Resistance: Is It Real and How Does It Impact on Dermatology? (2013)
Hot Topics: Minocycline vs Doxycycline (2012)
Open Forum: Clinical Tips, Questions and Answers (multiple years)
Seminar at Sea
Speaker (2008-present)
Drug Actions, Reactions, and Interactions
Acne, Rosacea, Eczema, Psoriasis and Other Common Dermatoses
So Many Drugs, So Little Time: Therapeutic Update
Clinical Pearls
Real World Dermatology for Dermatology Residents
Las Vegas, Nevada (2011-present)
Program Co-Director and Speaker
What You Need To Know: Acne and Rosacea (speaker)
What You Need To Know: Acne and Rosacea (speaker)
Actinic Keratosis Diagnosis and Management (2013, speaker)
South Beach Annual Symposium
Miami Beach. Florida (2006-present)
Medical Dermatology Session Co-Director, Moderator and Speaker
Presentations on acne vulgaris, rosacea, atopic dermatitis/eczematous dermatitis,
psoriasis, antibiotic therapy, topical immunomodulator therapy, epidermal barrier
therapies, actinic keratosis, non-melanoma skin cancer, fungal infections, viral
infections, bacterial infections
DERM 2014
Las Vegas, Nevada (July 2014)
Clinical Program Co-Director and Speaker
Program for Dermatology Physician Assistance and Nurse Practitioners
Speaker: Antibiotic Stewardship in Dermatology
Co-Speaker: Diagnosis and Management Onychomycosis with Review of Advances in
Topical Management
Speaker: Management of Actinic Keratoses
Page 9 of 31
Co-Speaker: Medical Therapies for Acne Vulgaris
Speaker: Understanding the Clinical Relevance of Barrier
Scientific Panel on Antibiotic Use in Dermatology (SPAUD)
Las Vegas, Nevada (2006-present)
Program Founder, Chairman, Moderator, and Speaker
Meeting (April 2006) and supplement publication in Cutis (June 2007); poster and
newsletter
Meeting (November 2007) and supplement publication in Cutis (August 2008); poster,
newsletter
Meeting under AARS (September 2014); other initiatives in development
Rosacea International Study Group (RISG) Annual Meeting
Member and Speaker (2009-present)
Multiple locations (New York, N, USA; Chicago, Illinois, USA; Berlin, Germany; Dublin,
Ireland; Bourdeaux, France)
Presentations: subantimicrobial therapy, pathophysiology and management of rosacea,
causes of erythema of rosacea and correlation with management, natural history and
progression of rosacea, observation and challenges with topical alpha-adrenergic
therapy in rosacea
Publication of supplement in Journal of American Academy of Dermatology (December
2013)
American Podiatric Medical Association Annual Meeting
Speaker: Management of Cutaneous Fungal Infections
Las Vegas, NV (August 2013)
Speaker: Antifungal Therapy Update; Clinically Significant Drug Interactions
Boston (August 2004)
Speaker: Safety of Oral Antifungal Agents
Philadelphia, PA (August 2000)
Scientific Advisory Panel on Maintenance of the Structural and Functional Integrity
of the Skin: Focus on the Physiology and Pathophysiology of the Stratum Corneum
and Epidermal “Barrier” in Healthy and Diseased Skin
Las Vegas, Nevada (April 2011 meeting; subsequent publications)
Program Director, Founder, and Speaker
Speaker: What is the “Epidermal Barrier”? What Are It’s Functions?
Speaker: Stratum Corneum Barrier Structure and Function in Health and Diseases Skin
Seven publications followed related to this project in Journal of Clinical and Aesthetic
Dermatology with multiple authors on stratum corneum structure and function in
normal skin, compromised skin, and diseases skin: role of Raman spectroscopy; effect of
topical corticosteroid on barrier functions; the epidermal barrier in acne vulgaris, effects
Page 10 of 31
of oral isotretinoin on the stratum corneum and barrier structure and functions; 3-part
article series on atopic dermatitis and the epidermal barrier.
Mount Sinai Medical Center Annual Dermatology Update Meeting
New York, New York (2007 – present)
So Many Drugs, So Little Time (multiple years)
What’s New in the Medicine Cabinet? (multiple years)
Drug Development in Dermatology: Where Are We Now? (2012)
American Osteopathic College of Dermatology Annual and Midyear Meetings
Speaker, Session Director, Course Director (1993 – present)
Onychomycosis: What Is New in Diagnosis and Management? (2014)
Status Report on Actinic Keratosis Diagnosis and Management (2013, 2014)
Therapeutic Update (multiple years)
So Many Drugs, So Little Time (multiple years)
Proper Utilization of Biopsy Techniques for Pigmented Skin Lesions (multiple years)
Cases About Faces (multiple years)
Hair & Nails & Ant-Aging
Speaker
Capri, Italy (2012-2013)
So Many Drugs, So Little Time: What Does the Dermatologist Need to Know to
Improve Treatment Outcomes (May 2013)
Connecting the Dots Between the Pathogebesis & Management of Rosacea (May 2013)
The Functional and Structural Integrity of the Stratum Corneum: Relevance to Skin
Health and Disease (May 2012)
Status Report on Acne and Rosacea (May 2012)
Ohio Dermatological Association 30th Annual Meeting
Speaker
Columbus, Ohio (October 2013)
Four-Hour Dermatology Teaching Session for Residents (Ohio State University, Case
Western) Ohio University, Cleveland Clinic, Cuyahoga Falls)
So Many Drugs, So Little Time: A Therapeutic Update
Las Vegas Dermatology Seminar
Speaker
Las Vegas, Nevada (October 2013)
Great Cases from the Las Vegas Dermatology Society
(multi-speaker session)
Dermatology Symposium for Private Practice Dermatologists in Italy
Speaker
Page 11 of 31
Pugniochuso, Italy (May 2013)
Status Report on the Management of Rosacea
Dermatology Update 2012
Speaker
Vancouver, Canada (October 2013)
Speaker
Inflammation in the Pathogenesis of Acne: What Is The Clinical Relevance?
Why Is Skin Care So Important To You?
Managing the Erythema of Rosacea: What Do We Know About Topical Brimonidine?
Connecting the Dots in Acne & Rosacea
European Academy of Dermatology and Venereology 21st Annual Congress
Prague, Czechoslovakia (September 2012)
Program Co-Chairman and Speaker
No More Red Symposium
Speaker: Connecting the Dots in Rosacea
Moderator and Panelist: Open Panel Discussion
Skin Curriculum Overview for Physician Extenders (Annual SCOPE Course)*
Program Co-Director and Co-Founder
Multiple cities (2004-2010)
(*annual core curriculum national meeting for physician assistants and nurse
practitioners employed and/or supervised by dermatologists in dermatology practices)
North American Clinical Dermatology Society
Dublin, Ireland (July 2008)
Speaker
Status Report on Acne and Rosacea
Drug Actions, Reactions & Interactions
Dermatology Foundation Clinical Symposium
Amelia Island, Florida (April 2008)
Speaker
Topical Barrier Repair Creams: What Are They & What Do They Do?
Dermatology All That Jazz Meeting
Tulane University Department of Dermatology
Speaker
So Many Drugs, So Little Time: A Therapeutic Update (April 2008)
What’s New in the Medicine Cabinet for Acne & Rosacea? (April 2008)
Update on Rosacea and Acne (April 2001)
Page 12 of 31
World Congress of Dermatology
Buenos Aires, Argentina (October 2007)
Speaker
Antibiotic Resistance: Issues of Significance to Dermatology
Florida Society of Dermatology and Dermatologic Surgery
West Palm Beach, Florida (May 2007)
Speaker
Drug Actions, Raections & Interactions
Acne Update/iPledge Update
New Mexico Dermatology Society
Albuquerque, New Mexico (April 2007)
Speaker
Therapeutic Update
Update on Antibiotic Therapy
Taiwan Dermatology Society
Kaohsiung City, Taiwan (May 2006)
Speaker
Update on Acne Vulgaris
Utah Dermatological Association
Springdale, Utah (May 2004)
Speaker
Antibiotic Therapy
Drug Actions, Reactions & Interactions
Cleveland Clinic Foundation Dermatology Department
Cleveland, Ohio (March 2004)
Speaker
Update on Antibiotic Therapy in Dermatology
Pacific Dermatology Association
Las Vegas, Nevada (August 2003)
Program Chairman and Speaker
Therapeutic Potpourri
Medical Management of Cutaneous Epithelial Malignancy
Council for Nail Disorders
Washington, DC (March 2001)
Program Co-Director
Page 13 of 31
Illinois Podiatric Medical Association Convention
Chicago, Illinois (September 2000)
Speaker
Onychomycosis in Special Populations
Regional Congress of Dermatology
Kuala Lumpur, Malaysia (July 2000)
Antifungal Therapy Update
Baja Crippled Children Podiatry Project
Los Angeles, California
Speaker
Dermatologic Disorders of Interest to the Podiatrist (January 2001)
Podiatric Dermatology: A Case Study Review (January 2000)
Dermatology Grand Rounds Invited Guest Faculty
University of Naples, Italy Department of Dermatology 2013
Harbor UCLA Medical Center Dermatology 2013
Penn State University Hershey Medical Center Department of Dermatology 2012
Ohio State University Department of Dermatology 2012
St. Lukes/Roosevelt Hospital, New York Department of Dermatology 2012
University of Miami Department of Dermatology 2011
Mount Sinai Medical Center, New York Department of Dermatology 2010
University of California Irvine 2009
Cleveland Clinic Foundation Department of Dermatology 2008, 2004
Loma Linda University Department of Dermatology 2006, 2000
University of Oklahoma Department of Dermatology 2005
University of Tennessee Department of Dermatology 2005
University of Bologna, Italy Department of Dermatology 2003, 2004
Louisiana State University Medical Center 1996
Publications
Textbook Chapters
Kim S, Michaels BD, Kim GK, Del Rosso JQ. Systemic antibacterial agents. In:
Wolverton SE, Ed. Comprehensive Dermatologic Drug Therapy, 3rd Edition, El;sevierSaunders, Philadelphia, PA, USA. 2013, pp 61-97.
(served as senior author overseeing entire chapter; wrote the introductory section, the
tetracyclines section, and the macrolides section)
Del Rosso JQ. Topical antibiotics. In: Shalita AR, Del Rosso JQ, Webster GF. Eds, Acne
Vulgaris, informaHealth, London, UK and New York, NY, 2011, pp 95-104.
Page 14 of 31
Del Rosso JQ. Oral antibiotics. In: Shalita AR, Del Rosso JQ, Webster GF. Eds, Acne
Vulgaris, informaHealth, London, UK and New York, NY, 2011, pp 113-124.
Williams V, Rosen T, Ceilley R, Del Rosso JQ, Stockfleth E. Topical treatment of skin
cancer. In: Rigel DS, Robinson JK, Ross M, Friedman RJ, Cockerell CJ, Lim HW,
Stockfleth E, Kirkwood JM, Eds, Cancer of the Skin, 2nd Edition, Elsevier-Saunders,
Philadelphia, PA, USA. 2011, pp 462-476.
Ceilley RI, Del Rosso JQ. Topical chemotherapy for the treatment of skin cancer. In:
Rigel DS, Friedman RJ, Dzubow LM, Reintgen DS, Bystryn J-C, Marks R, Eds, Cancer of
the Skin, 1st Edition. Elsevier-Saunders, Philadelphia, PA, USA. 2005, pp 619-630.
Del Rosso JQ, Kim GK. Topical therapy for acne scarring. In: Tosti A, Pia De Padova M,
Beer KR, Eds. Acne scars: classification and treatment, informaHealthcare, London, UK,
2010.
Del Rosso JQ, Daniel III CR. Disorders of the nail. In: Dale DC, Federman DD, et al, Eds.
WebMD Scientific American Medicine 2003 Edition, WebMD Professional Publishing,
New York, NY, USA, 2003, pp 519-525.
Del Rosso JQ, Basuk PJ, Scher RK, Ricci AR. Dermatologic diseases of the nail unit. In:
Scher RK, Daniel III CR, Eds, Nails: Diagnosis, Therapy Surgery, 2nd Edition,
WB Saunders Company, Philadelphia, PA, USA. 1997, pp 172-200.
Articles (peer-reviewed, indexed journals)
Del Rosso JQ. The role of topical antifungal therapy for onychomycosis and the
emergence of newer agents. J Clin Aesthet Dermatol. 2014 Jul;7(7):10-8.
Del Rosso JQ, Kircik LH. Transitioning from brand to generic with topical products and
the importance of maintaining the formulation and therapeutic profiles of the original
product: focus on clocortolone pivalate 0.1% cream. J Drugs Dermatol. 2014
Jul;13(7):s77-83.
Levin J, Fallon Friedlander S, Del Rosso JQ. Atopic dermatitis and the stratum corneum:
part 3: the immune system in atopic dermatitis. J Clin Aesthet Dermatol. 2013
Dec;6(12):37-44.
Levin J, Friedlander SF, Del Rosso JQ. Atopic dermatitis and the stratum corneum: part
2: other structural and functional characteristics of the stratum corneum barrier in
atopic skin. J Clin Aesthet Dermatol. 2013 Nov;6(11):49-54.
Page 15 of 31
Levin J, Friedlander SF, Del Rosso JQ. Atopic dermatitis and the stratum corneum: part
1: the role of filaggrin in the stratum corneum barrier and atopic skin. J Clin Aesthet
Dermatol. 2013 Oct;6(10):16-22.
Del Rosso JQ, Brandt S, The role of skin care as an integral component in the
management of acne vulgaris: part 2: tolerability and performance of a designated skin
care regimen using a foam wash and moisturizer SPF 30 in patients with acne vulgaris
undergoing active treatment. J Clin Aesthet Dermatol. 2013 Dec;6(12):28-36.
Del Rosso JQ. The role of skin care as an integral component in the management of acne
vulgaris: part 1: the importance of cleanser and moisturizer ingredients, design, and
product selection. J Clin Aesthet Dermatol. 2013 Dec;6(12):19-27.
Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti E, Eichenfield LF, Stein-Gold
L, Berson D, Zaenglein A. Consensus recommendations from the American Acne &
Rosacea Society on the management of rosacea, part 5: a guide on the management of
rosacea. Cutis. 2014 Mar;93(3):134-8.
Tanghetti E, Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Eichenfield LF, Stein-Gold
L, Berson D, Zaenglein A. Consensus recommendations from the American Acne &
Rosacea Society on the management of rosacea, part 4: a status report on physical
modalities and devices. Cutis. 2014 Feb;93(2):71-6.
Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti E, Eichenfield LF, Stein-Gold
L, Berson D, Zaenglein A. Consensus recommendations from the American Acne &
Rosacea Society on the management of rosacea, part 3: a status report on systemic
therapies. Cutis. 2014 Jan;93(1):18-28.
Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti E, Eichenfield LF, Stein-Gold
L, Berson D, Zaenglein A. Consensus recommendations from the American Acne &
Rosacea Society on the management of rosacea, part 2: a status report on topical agents.
Cutis. 2013 Dec;92(6):277-84
Del Rosso JQ, Thiboutot D, Gallo R, Webster G, Tanghetti E, Eichenfield LF, Stein-Gold
L, Berson D, Zaenglein A. Consensus recommendations from the American Acne &
Rosacea Society on the management of rosacea, part 1: a status report on the disease
state, general measures, and adjunctive skin care. Cutis. 2013 Nov;92(5):234-40.
Leyden JJ, Del Rosso JQ, Baum EW. The use of isotretinoin in the treatment of acne
vulgaris: clinical considerations and future directions. J Clin Aesthet Dermatol. 2014
Feb;7(2 Suppl):S3-S21.
Page 16 of 31
Del Rosso JQ, Plattner JJ. From the Test Tube to the Treatment Room: Fundamentals of
Boron-containing Compounds and their Relevance to Dermatology. J Clin Aesthet
Dermatol. 2014 Feb;7(2):13-21.
Del Rosso JQ. Incorporation of a barrier protection cream in the management of chronic
hand dermatitis: focus on data supporting an established hand protectant formulation
and modifications designed to assist in barrier repair. J Clin Aesthet Dermatol. 2014
Feb;7(2):40-8.
Del Rosso JQ, Zeichner J. What's New in the Medicine Cabinet?: A Panoramic Review of
Clinically Relevant Information for the Busy Dermatologist. J Clin Aesthet Dermatol.
2014 Jan;7(1):26-30.
Two AM, Del Rosso JQ. Kallikrein 5-mediated inflammation in rosacea: clinically
relevant correlations with acute and chronic manifestations in rosacea and how
individual treatments may provide therapeutic benefit. J Clin Aesthet Dermatol. 2014
Jan;7(1):20-5.
Del Rosso JQ, Kircik LH. Optimizing topical antifungal therapy for superficial
cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis. J
Drugs Dermatol. 2013 Nov;12(11 Suppl):s165-71.
Del Rosso JQ, Cash K. Topical corticosteroid application and the structural and
functional integrity of the epidermal barrier. J Clin Aesthet Dermatol. 2013
Nov;6(11):20-7.
Kircik L, Lebwohl MG, Del Rosso JQ, Bagel J, Stein Gold L, Weiss JS. Clinical study
results of desoximetasone spray, 0.25% in moderate to severe plaque psoriasis. J Drugs
Dermatol. 2013 Dec;12(12):1404-10.
Del Rosso JQ. Management of facial erythema of rosacea: what is the role of topical αadrenergic receptor agonist therapy? J Am Acad Dermatol. 2013 Dec;69(6 Suppl 1):S4456.
Del Rosso JQ, Kircik LH. The sequence of inflammation, relevant biomarkers, and the
pathogenesis of acne vulgaris: what does recent research show and what does it mean
to the clinician? J Drugs Dermatol. 2013 Aug;12(8 Suppl):s109-15.
Lebwohl MG, Del Rosso JQ, Abramovits W, Berman B, Cohen DE, Guttman E, Mancini
AJ, Schachner LA. Pathways to managing atopic dermatitis: consensus from the experts.
J Clin Aesthet Dermatol. 2013 Jul;6(7 Suppl):S2-S18.
Del Rosso JQ, Kircik LH. The integration of physiologically-targeted skin care in the
management of atopic dermatitis: focus on the use of a cleanser and moisturizer system
Page 17 of 31
incorporating a ceramide precursor, filaggrin degradation products, and specific "skinbarrier-friendly" excipients. J Drugs Dermatol. 2013 Jul 1;12(7):s85-91.
Del Rosso JQ. Application of protease technology in dermatology: rationale for
incorporation into skin care with initial observations on formulations designed for skin
cleansing, maintenance of hydration, and restoration of the epidermal permeability
barrier. J Clin Aesthet Dermatol. 2013 Jun;6(6):14-22.
Coda AB, Hata T, Miller J, Audish D, Kotol P, Two A, Shafiq F, Yamasaki K, Harper JC,
Del Rosso JQ, Gallo RL. Cathelicidin, kallikrein 5, and serine protease activity is
inhibited during treatment of rosacea with azelaic acid 15% gel. J Am Acad Dermatol.
2013 Oct;69(4):570-7.
Del Rosso JQ. Clinical relevance of skin barrier changes associated with the use of oral
isotretinoin: the importance of barrier repair therapy in patient management. J Drugs
Dermatol. 2013 Jun 1;12(6):626-31.
Del Rosso JQ, Gallo RL, Tanghetti E, Webster G, Thiboutot D. An evaluation of
potential correlations between pathophysiologic mechanisms, clinical manifestations,
and management of rosacea. Cutis. 2013 Mar;91(3 Suppl):1-8.
Del Rosso JQ, Reece B, Smith K, Miller T. Efinaconazole 10% solution: a new topical
treatment for onychomycosis: contact sensitization and skin irritation potential. J Clin
Aesthet Dermatol. 2013 Mar;6(3):20-4.
Del Rosso JQ, Tanghetti E. A status report on topical tazarotene in the management of
acne vulgaris. J Drugs Dermatol. 2013 Mar;12(3):s53-8.
Kim GK, Del Rosso JQ. Topical pimecrolimus 1% cream in the treatment of seborrheic
dermatitis. J Clin Aesthet Dermatol. 2013 Feb;6(2):29-35.
Thiboutot D, Del Rosso JQ. Acne vulgaris and the epidermal barrier: Is acne vulgaris
associated with inherent epidermal abnormalities that cause impairment of barrier
functions? Do any topical acne therapies alter the structural and/or functional integrity
of the epidermal barrier? J Clin Aesthet Dermatol. 2013 Feb;6(2):18-24.
Del Rosso JQ, Kircik LH. The role of a midpotency topical corticosteroid and the clinical
relevance of formulation characteristics in the management of commonly encountered
eczematous and inflammatory dermatoses in adults and children: focus on the
pharmacologic properties of clocortolone pivalate 0.1% cream. J Drugs Dermatol. 2013
Feb;12(2):s5-s10.
Winkelmann RR, Kim GK, Del Rosso JQ. Treatment of cutaneous lupus erythematosus:
review and assessment of treatment benefits based on Oxford Centre for Evidencebased Medicine Criteria. J Clin Aesthet Dermatol. 2013 Jan;6(1):27-38.
Page 18 of 31
Del Rosso JQ, Kircik LH. Not all topical corticosteroids are created equal! optimizing
therapeutic outcomes through better understanding of vehicle formulations, compound
selection,and methods of application. J Drugs Dermatol. 2012 Dec;11(12):s5-8.
Del Rosso JQ. Face to face with oral isotretinoin: a closer look at the spectrum of
therapeutic outcomes and why some patients need repeated courses. J Clin Aesthet
Dermatol. 2012 Nov;5(11):17-24.
Kircik LH, Del Rosso JQ. The treatment of inflammatory facial dermatoses with topical
corticosteroids: focus on clocortolone pivalate 0.1% cream. J Drugs Dermatol. 2012
Oct;11(10):1194-8.
Del Rosso JQ, Kircik L. A comprehensive review of clocortolone pivalate 0.1% cream:
structural development, formulation characteristics, and studies supporting treatment
of corticosteroid-responsive dermatoses. J Clin Aesthet Dermatol. 2012 Jul;5(7):20-4.
Tan J, Wolfe B, Weiss J, Stein-Gold L, Bikowski J, Del Rosso J, Webster GF, Lucky A,
Thiboutot D, Wilkin J, Leyden J, Chren MM. Acne severity grading: determining
essential clinical components and features using a Delphi consensus. J Am Acad
Dermatol. 2012 Aug;67(2):187-93.
Bhatia ND, Del Rosso JQ. Optimal management of papulopustular rosacea: rationale for
combination therapy. J Drugs Dermatol. 2012 Jul;11(7):838-44.
Leyden JJ, Del Rosso JQ. The effect of benzoyl peroxide 9.8% emollient foam on
reduction of Propionibacterium acnes on the back using a short contact therapy approach.
J Drugs Dermatol. 2012 Jul;11(7):830-3.
Del Rosso JQ, Preston NJ, Caveney SW, Gottschalk RW. Effectiveness and safety of
modified-release doxycycline capsules once daily for papulopustular rosacea
monotherapy results from a large community-based trial in subgroups based on
gender. J Drugs Dermatol. 2012 Jun;11(6):703-7.
Del Rosso JQ, Gallo RL, Kircik L, Thiboutot D, Baldwin HE, Cohen D. Why is rosacea
considered to be an inflammatory disorder? The primary role, clinical relevance, and
therapeutic correlations of abnormal innate immune response in rosacea-prone skin.
J Drugs Dermatol. 2012 Jun;11(6):694-700.
Kim GK, Del Rosso JQ. Oral spironolactone in post-teenage female patients with acne
vulgaris: practical considerations for the clinician based on current data and clinical
experience. J Clin Aesthet Dermatol. 2012 Mar;5(3):37-50.
Del Rosso JQ. Advances in understanding and managing rosacea: part 2: the central
role, evaluation, and medical management of diffuse and persistent facial erythema of
rosacea. J Clin Aesthet Dermatol. 2012 Mar;5(3):26-36.
Page 19 of 31
Del Rosso JQ. Advances in understanding and managing rosacea: part 1: connecting the
dots between pathophysiological mechanisms and common clinical features of rosacea
with emphasis on vascular changes and facial erythema. J Clin Aesthet Dermatol. 2012
Mar;5(3):16-25.
Michaels BD, Del Rosso JQ. Tinea capitis in infants: recognition, evaluation, and
management suggestions. J Clin Aesthet Dermatol. 2012 Feb;5(2):49-59.
Del Rosso JQ, Harper J, Pillai R, Moore R. Tretinoin photostability: comparison of
micronized tretinoin (0.05%) gel and tretinoin (0.025%) gel following exposure to
ultraviolet a light. J Clin Aesthet Dermatol. 2012 Jan;5(1):27-9.
Kircik LH, Del Rosso JQ. Nonsteroidal treatment of atopic dermatitis in pediatric
patients with a ceramide-dominant topical emulsion formulated with an optimized
ratio of physiological lipids. J Clin Aesthet Dermatol. 2011 Dec;4(12):25-31.
Del Rosso JQ, Levin J. Clinical relevance of maintaining the structural and functional
integrity of the stratum corneum: why is it important to you? J Drugs Dermatol. 2011
Oct;10(10 Suppl):s5-12.
Park H, Del Rosso JQ. Use of oral isotretinoin in the management of rosacea. J Clin
Aesthet Dermatol. 2011 Sep;4(9):54-61.
Del Rosso JQ, Levin J. The clinical relevance of maintaining the functional integrity of
the stratum corneum in both healthy and disease-affected skin. J Clin Aesthet Dermatol.
2011 Sep;4(9):22-42.
Del Rosso JQ, Bhatia N. Azelaic acid gel 15% in the management of papulopustular
rosacea: a status report on available efficacy data and clinical application. Cutis. 2011
Aug;88(2):67-72.
Ritvo E, Del Rosso JQ, Stillman MA, La Riche C. Psychosocial judgements and
perceptions of adolescents with acne vulgaris: A blinded, controlled comparison of
adult and peer evaluations. Biopsychosoc Med. 2011 Aug 13;5(1):11.
Del Rosso JQ. Management of papulopustular rosacea and perioral dermatitis with
emphasis on iatrogenic causation or exacerbation of inflammatory facial dermatoses:
use of doxycycline-modified release 40 mg capsule once daily in combination with
properly selected skin care as an effective approach. J Clin Aesthet Dermatol. 2011
Aug;4(8):20-30.
Del Rosso JQ. Current regimens and guideline implications for the treatment of actinic
keratosis: proceedings of a clinical roundtable at the 2011 Winter Clinical Dermatology
Conference. Cutis. 2011 Jul;88(1):suppl 1-8.
Page 20 of 31
Del Rosso JQ. Repair and maintenance of the epidermal barrier in patients diagnosed
with atopic dermatitis: an evaluation of the components of a body wash-moisturizer
skin care regimen directed at management of atopic skin. J Clin Aesthet Dermatol. 2011
Jun;4(6):45-55.
Bellew S, Thiboutot D, Del Rosso JQ. Pathogenesis of acne vulgaris: what's new, what's
interesting and what may be clinically relevant. J Drugs Dermatol. 2011 Jun;10(6):582-5.
Del Rosso JQ. Adult seborrheic dermatitis: a status report on practical topical
management. J Clin Aesthet Dermatol. 2011 May;4(5):32-8.
Kircik LH, Del Rosso JQ, Aversa D. Evaluating clinical use of a ceramide-dominant,
physiologic lipid-based topical emulsion for atopic dermatitis. J Clin Aesthet Dermatol.
2011 Mar;4(3):34-40.
Kim GK. Del Rosso JQ. Status report on the management of dermatofibrosarcoma
protuberans: is there a viable role for the use of imatinib mesylate? In which cases may
it be therapeutically helpful and in which cases not? J Clin Aesthet Dermatol.
2011 Mar;4(3):17-26.
Del Rosso JQ. Wound care in the dermatology office: where are we in 2011? J Am Acad
Dermatol. 2011 Mar;64(3 Suppl):S1-7.
Leyden JJ, Del Rosso JQ. Oral antibiotic therapy for acne vulgaris: pharmacokinetic and
pharmacodynamic perspectives. J Clin Aesthet Dermatol. 2011 Feb;4(2):40-7.
Del Rosso JQ. Effectiveness and safety of doxycycline 40 mg (30-mg immediate-release
and 10-mg delayed-release beads) once daily as add-on therapy to existing topical
regimens for the treatment of papulopustular rosacea: results from a community-based
trial. Cutis. 2010 Nov;86(5 Suppl):16-25.
Zeichner JA, Lebwohl MG, Menter A, Bagel J, Del Rosso JQ, Elewski BE, Feldman SR,
Kircik LH, Koo J, Gold LS, Tanghetti E; Psoriasis Process of Care Consensus Panel.
Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis.
2010 Sep;86(3 Suppl):5-31.
Del Rosso JQ, Pillai R, Moore R. Absence of degradation of tretinoin when benzoyl
peroxide is combined with an optimized formulation of tretinoin gel (0.05%). J Clin
Aesthet Dermatol. 2010 Oct;3(10):26-8.
Kim GK. Del Rosso JQ. The rationale behind topical vitamin D analogs in the treatment
of psoriasis: where does topical calcitriol fit in? J Clin Aesthet Dermatol. 2010
Aug;3(8):46-53.
Page 21 of 31
Kim GK, Del Rosso JQ. Laser and light-based therapies for acne vulgaris: a current
guide based on available data. J Drugs Dermatol. 2010 Jun;9(6):614-21.
Momin SB, Peterson A, Del Rosso JQ. A status report on drug-associated acne and
acneiform eruptions. J Drugs Dermatol. 2010 Jun;9(6):627-36.
Del Rosso JQ, Bruce S, Jarratt M, Menter A, Staedtler G. Efficacy of topical azelaic acid
(AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral
doxycycline 40 mg in mild-to-moderate papulopustular rosacea. J Drugs Dermatol. 2010
Jun;9(6):607-13.
Tanghetti E, Dhawan S, Green L, Del Rosso J, Draelos Z, Leyden J, Shalita A, Glaser DA,
Grimes P, Webster G, Barnett P, Le Gall N. Randomized comparison of the safety and
efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients
with at least moderate facial acne vulgaris. J Drugs Dermatol. 2010 May;9(5):549-58.
J Clin Aesthet Dermatol. 2010 Apr;3(4):49-54.
Kim GK, Del Rosso JQ. The risk of fluoroquinolone-induced tendinopathy and tendon
rupture: what does the clinician need to know? J Clin Aesthet Dermatol. 2010
Apr;3(4):49-54.
Kircik L, Del Rosso JQ. Comparative efficacy and safety results of topical hemostatic
powder and sterile compressed foam sponge in second intention healing following
Mohs micrographic surgery. J Drugs Dermatol. 2010 Feb;9(2):137-40.
Kim GK, Del Rosso JQ. Drug-provoked psoriasis: is it drug induced or drug
aggravated?: understanding pathophysiology and clinical relevance. J Clin Aesthet
Dermatol. 2010 Jan;3(1):32-8.
Del Rosso JQ, Schmidt NF. A review of the anti-inflammatory properties of clindamycin
in the treatment of acne vulgaris. Cutis. 2010 Jan;85(1):15-24.
Michaels BD, Del Rosso JQ, Momin SB. Avoiding the legal "blemish": medicolegal
pitfalls in dermatology. J Clin Aesthet Dermatol. 2009 Dec;2(12):35-43.
Del Rosso JQ. Perspectives on seborrheic dermatitis: looking back to move ahead. Clin
Dermatol. 2009 Nov-Dec;27(6 Suppl):S39-40.
Kim GK. Del Rosso JQ. Seborrheic dermatitis and Malassezia species: how are they
related. J Clin Aesthet Dermatol. 2009 Nov;2(11):14-7.
Bellew S, Del Rosso JQ, Kim GK. Skin cancer in asians: part 2: melanoma. J Clin Aesthet
Dermatol. 2009 Oct;2(10):34-6.
Del Rosso JQ, Kim GK. Topical antibiotics: therapeutic value or ecologic mischief?
Dermatol Ther. 2009 Sep-Oct;22(5):398-406.
Page 22 of 31
Del Rosso JQ, Bhambri S. Daily application of fluocinonide 0.1% cream for the treatment
of atopic dermatitis. J Clin Aesthet Dermatol. 2009 Sep;2(9):24-32.
Kim GK, Del Rosso JQ, Bellew S. Skin cancer in asians: part 1: nonmelanoma skin
cancer. J Clin Aesthet Dermatol. 2009 Aug;2(8):39-42.
Bellew S, Del Rosso JQ, Mobini N. Primary carcinosarcoma of the ear: case report and
review of the literature. J Clin Aesthet Dermatol. 2009 Aug;2(8):33-5.
Del Rosso JQ. The use of moisturizers as an integral component of topical therapy for
rosacea: clinical results based on the Assessment of Skin Characteristics Study. Cutis.
2009 Aug;84(2):72-6.
Del Rosso JQ. A 6% benzoyl peroxide foaming cloth cleanser used in the treatment of
acne vulgaris: aesthetic characteristics, patient preference considerations, and impact on
compliance with treatment. J Clin Aesthet Dermatol. 2009 Jul;2(7):26-9.
Del Rosso JQ. Anti-inflammatory dose doxycycline in the treatment of rosacea. J Drugs
Dermatol. 2009 Jul;8(7):664-8.
Thiboutot DM, Fleischer AB, Del Rosso JQ, Rich P. A multicenter study of topical
azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic
acid 15% gel as maintenance monotherapy. J Drugs Dermatol. 2009 Jul;8(7):639-48.
Thiboutot D, Eichenfield L, Shalita A, Del Rosso JQ, Swinyer L, Tanghetti E, Tschen E,
Parr LA. 3-step acne system containing solubilized benzoyl peroxide versus
clindamycin-benzoyl peroxide. Cutis. 2009 Jul;84(1):48-55.
Bhambri S, Del Rosso JQ, Bhambri A. Pathogenesis of acne vulgaris: recent advances. J
Drugs Dermatol. 2009 Jul;8(7):615-8.
Del Rosso JQ, Baldwin H, Keri J, Mancini A, Gold LS, Webster GF. Current approach to
acne management: a community-based analysis. Cutis. 2009 Jun;83(6 Suppl):5-21.
Momin SB1, Del Rosso JQ, Michaels B, Mobini N. Acute generalized exanthematous
pustulosis: an enigmatic drug-induced reaction. Cutis. 2009 Jun;83(6):291-8.
Kircik LH, Del Rosso JQ. Anti-TNF agents for the treatment of psoriasis. J Drugs
Dermatol. 2009 Jun;8(6):546-59.
Del Rosso JQ, Sofen H, Leshin B, Meng T, Kulp J, Levy S. Safety and efficacy of multiple
16-week courses of topical imiquimod for the treatment of large areas of skin involved
with actinic keratoses. J Clin Aesthet Dermatol. 2009 Apr;2(4):20-8.
Del Rosso JQ, Lehman PA, Raney SG, Impact of order of application of moisturizers on
percutaneous absorption kinetics: evaluation of sequential application of moisturizer
Page 23 of 31
lotions and azelaic acid gel 15% using a human skin model. Cutis. 2009 Mar;83(3):11924.
Momin SB, Richardson BS, Bryan MG, Del Rosso JQ, Mobini N. Mycetoma clinically
masquerading as squamous cell carcinoma: case report and literature review. J Clin
Aesthet Dermatol. 2009 Feb;2(2):26-31.
Del Rosso JQ, Kim G. Optimizing use of oral antibiotics in acne vulgaris. Dermatol Clin.
2009 Jan;27(1):33-42.
Bhambri S, Bhambri A, Del Rosso JQ. Atypical mycobacterial cutaneous infections.
Dermatol Clin. 2009 Jan;27(1):63-73.
Del Rosso JQ. Oral antibiotic drug interactions of clinical significance to dermatologists.
Dermatol Clin. 2009 Jan;27(1):91-4.
Bikowski JB, Del Rosso JQ. Demodex dermatitis: a retrospective analysis of clinical
diagnosis and successful treatment with topical crotamiton. J Clin Aesthet Dermatol.
2009 Jan;2(1):20-5.
Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne
vulgaris and other inflammatory skin disorders: a status report. Dermatol Clin. 2009
Jan;27(1):1-15.
Del Rosso JQ. Benzoyl peroxide cleansers for the treatment of acne vulgaris: status
report on available data. Cutis. 2008 Nov;82(5):336-42.
Del Rosso JQ. Selection of therapy for acne vulgaris: balancing concerns about antibiotic
resistance. Cutis. 2008 Nov;82(5 Suppl):12-6.
Del Rosso JQ. Update from the Scientific Panel on Antibiotic Use in Dermatology:
clinical considerations for the dermatologist. Cutis. 2008 Aug;82(2 Suppl 2):3-4.
Del Rosso JQ1, Leyden JJ, Thiboutot D, Webster GF. Antibiotic use in acne vulgaris and
rosacea: clinical considerations and resistance issues of significance to dermatologists.
Cutis. 2008 Aug;82(2 Suppl 2):5-12.
Del Rosso JQ. Comprehensive management of patients with superficial fungal
infections: the role of sertaconazole nitrate. Cutis. 2008 Jun;81(6 Suppl):4-18.
Del Rosso JQ, Schlessinger J, Werschler P. Comparison of anti-inflammatory dose
doxycycline versus doxycycline 100 mg in the treatment of rosacea. J Drugs Dermatol.
2008 Jun;7(6):573-6.
Thiboutot DM, Fleischer AB Jr, Del Rosso JQ, Graupe K. Azelaic acid 15% gel once daily
versus twice daily in papulopustular rosacea. J Drugs Dermatol. 2008 Jun;7(6):541-6.
Page 24 of 31
Del Rosso JQ, Baldwin H, Webster G; American Acne & Rosacea Society. American
Acne & Rosacea Society rosacea medical management guidelines. J Drugs Dermatol.
2008 Jun;7(6):531-3.
Del Rosso JQ, Jitpraphai W, Bhambri S, Momin S. Clindamycin phosphate 1.2%tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability. Cutis. 2008
May;81(5):405-8.
Bhambri S, Desai A, Del Rosso JQ, Mobini N. Dermatofibrosarcoma protuberans: a case
report and review of the literature. J Clin Aesthet Dermatol. 2008 May;1(1):34-6.
Del Rosso JQ, Baum EW. Comprehensive medical management of rosacea: an interim
study report and literature review. J Clin Aesthet Dermatol. 2008 May;1(1):20-5.
Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G. Healthcare utilization and
costs of patients with rosacea in an insured population. J Drugs Dermatol. 2008
Jan;7(1):41-9.
Del Rosso JQ. Newer topical therapies for the treatment of acne vulgaris. Cutis. 2007
Nov;80(5):400-10.
Del Rosso JQ. Recently approved systemic therapies for acne vulgaris and rosacea. Cutis. 2007
Aug;80(2):113-20.
Bhambri S, Del Rosso JQ, Desai A. Oral trimethoprim/sulfamethoxazole in the treatment of
acne vulgaris. Cutis. 2007 Jun;79(6):430-4.
Del Rosso JQ. Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene
0.1% gel, and use in combination for acne vulgaris. J Drugs Dermatol. 2007 Jun;6(6):616-22.
Del Rosso JQ, Bikowski JB, Baum E, Smith J, Hawkes S, Benes V, Bhatia N. A closer look at
truncal acne vulgaris: prevalence, severity, and clinical significance. J Drugs Dermatol. 2007
Jun;6(6):597-600.
Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne vulgaris
and other inflammatory skin disorders: focus on antibiotic resistance. Cutis. 2007 Jun;79(6
Suppl):9-25.
Del Rosso JQ, Elston DM. Tackling the anterior nares and other sites of colonization:
implications for the dermatologist. Cutis. 2007 Jun;79(6 Suppl):52-9.
Del Rosso JQ, Webster GF, Jackson M, Rendon M, Rich P, Torok H, Bradshaw M. Two
randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg
doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad
Dermatol. 2007 May;56(5):791-802.
Del Rosso JQ. The treatment of viral infections and nonmelanoma skin cancers. Cutis. 2007
Apr;79(4 Suppl):29-35.
Page 25 of 31
Desai A, Kartono F, Del Rosso JQ. Systemic retinoid therapy: a status report on optimal use and
safety of long-term therapy. Dermatol Clin. 2007 Apr;25(2):185-93.
Webster G, Del Rosso JQ. Anti-inflammatory activity of tetracyclines. Dermatol Clin. 2007
Apr;25(2):133Del Rosso JQ, Leyden JJ. Status report on antibiotic resistance: implications for the
dermatologist. Dermatol Clin. 2007 Apr;25(2):127-32.
Del Rosso JQ, Draelos ZD, Jorizzo JL, Joseph WS, Ribotsky BM, Rich P. Modern methods to treat
superficial fungal disease. Cutis. 2007 Feb;79(2 Suppl):6-29.
Wolf JE Jr, Del Rosso JQ, The CLEAR trial: results of a large community-based study of
metronidazole gel in rosacea. Cutis. 2007 Jan;79(1):73-80.
Del Rosso JQ. Defining criteria used to evaluate response to treatment of acne vulgaris. Cutis.
2006 Aug;78(2):117-21.
Del Rosso JQ. Update on rosacea pathogenesis and correlation with medical therapeutic agents.
Cutis. 2006 Aug;78(2):97-100.
Del Rosso JQ. Combination topical therapy in the treatment of acne. Cutis. 2006 Aug;78(2 Suppl
1):5-12.
Ceilley RI, Del Rosso JQ. Current modalities and new advances in the treatment of basal cell
carcinoma. Int J Dermatol. 2006 May;45(5):489-98.
Del Rosso JQ. Clinical significance of brand versus generic formulations: focus on oral
minocycline. Cutis. 2006 Mar;77(3):153-6.
Del Rosso JQ. The use of topical azelaic acid for common skin disorders other than
inflammatory rosacea. Cutis. 2006 Feb;77(2 Suppl):22-4.
Del Rosso JQ, Tanghetti E. The clinical impact of vehicle technology using a patented
formulation of benzoyl peroxide 5%/clindamycin 1% gel: comparative assessments of skin
tolerability and evaluation of combination use with a topical retinoid. J Drugs Dermatol. 2006
Feb;5(2):160-4.
Del Rosso JQ. The use of topical imiquimod for the treatment of actinic keratosis: a status report.
Cutis. 2005 Oct;76(4):241-8.
Del Rosso JQ. A qualitative and quantitative assessment of the application and use of topical
acne medication by patients. Cutis. 2005 Aug;76(2):109-13.
Del Rosso JQ, Bikowski J. Topical metronidazole combination therapy in the clinical
management of rosacea. J Drugs Dermatol. 2005 Jul-Aug;4(4):473-80.
Del Rosso JQ. Antibiotic resistance: overview and significance in dermatology. Cutis. 2005
Apr;75(4 Suppl):12-8.
Page 26 of 31
Del Rosso JQ. Adjunctive skin care in the management of rosacea: cleansers, moisturizers, and
photoprotectants. Cutis. 2005 Mar;75(3 Suppl):17-21.
Del Rosso JQ. A status report on the use of subantimicrobial-dose doxycycline: a review of the
biologic and antimicrobial effects of the tetracyclines. Cutis. 2004 Aug;74(2):118-22.
Del Rosso JQ. Medical treatment of rosacea with emphasis on topical therapies. Expert Opin
Pharmacother. 2004 Jan;5(1):5-13.
Del Rosso JQ. Evaluating the role of topical therapies in the management of rosacea: focus on
combination sodium sulfacetamide and sulfur formulations. Cutis. 2004 Jan;73(1 Suppl):29-33.
Del Rosso JQ. New and emerging topical approaches for actinic keratoses. Cutis. 2003
Oct;72(4):273-6, 279.
Del Rosso JQ. Oral cephalosporin antibiotics: an overview of clinical pharmacology and
dermatologic applications. Cutis. 2003 Feb;71(2):153-7.
Del Rosso JQ. An update on newer topical therapies for actinic keratoses: advances and
applications. J Drugs Dermatol. 2003 Jan;2(1):35-9.
Del Rosso JQ. Cephalosporins in dermatology. Clin Dermatol. 2003 Jan-Feb;21(1):24-32.
Del Rosso JQ. A status report on the medical management of rosacea: focus on topical therapies.
Cutis. 2002 Nov;70(5):271-5.
Del Rosso JQ. Retinoic acid receptors and topical acne therapy: establishing the link between
gene expression and drug efficacy. Cutis. 2002 Aug;70(2):127-9.
Del Rosso JQ. Skin manifestations of drug reactions. Curr Allergy Asthma Rep. 2002
Jul;2(4):282-7.
Del Rosso JQ. Systemic therapy for rosacea: focus on oral antibiotic therapy and safety. Cutis.
2000 Oct;66(4 Suppl):7-13.
Del Rosso JQ. Current management of onychomycosis and dermatomycoses. Curr Infect Dis
Rep. 2000 Oct;2(5):438-445.
Gupta AK, Del Rosso JQ. An evaluation of intermittent therapies used to treat onychomycosis
and other dermatomycoses with the oral antifungal agents. Int J Dermatol. 2000 Jun;39(6):40111.
Del Rosso JQ, Gupta AK. The use of intermittent itraconazole therapy for superficial mycotic
infections: a review and update on the 'one week' approach. Int J Dermatol. 1999 Sep;38 Suppl
2:28-39.
Del Rosso JQ, Gupta AK. Management of tinea capitis. A status report. Postgrad Med. 1999
Jul;Spec No:38-45.
Gupta AK, Chang P, Del Rosso JQ, Adam P, Hofstader SL. Onychomycosis in children:
prevalence and management. Pediatr Dermatol. 1998 Nov-Dec;15(6):464-71.
Page 27 of 31
Del Rosso JQ, Zellis S, Gupta AK. Itraconazole in the treatment of superficial cutaneous and
mucosal Candida infections. J Am Osteopath Assoc. 1998 Sep;98(9):497-502.
Gupta AK, Del Rosso JQ, Lynde CW, Brown GH, Shear NH. Hepatitis associated with
terbinafine therapy: three case reports and a review of the literature. Clin Exp Dermatol.
1998 Mar;23(2):64-7.
Del Rosso JQ. Advances in the treatment of superficial fungal infections: focus on
onychomycosis and dry tinea pedis. J Am Osteopath Assoc. 1997 Jun;97(6):339-46.
Del Rosso JQ. Treatment of onychomycosis and tinea pedis with intermittent itraconazole
therapy. J Am Osteopath Assoc. 1996 Oct;96(10):607-9.
Geiss DF, Del Rosso JQ, Murphy J. Verruciform xanthoma of the glans penis: a benign clinical
simulant of genital malignancy. Cutis. 1993 May;51(5):369-72.
Del Rosso JQ. Treatment of Darier's disease with isotretinoin: report of a case. J Am Osteopath
Assoc. 1986 Oct;86(10):634-8.
Recognitions and Awards
Gold Triangle Award
American Academy of Dermatology
Chicago, Illinois
Co-Author: “ Rosacea Roadmap”
July 21, 2005
Gold Triangle Award
American Academy of Dermatology
New York, New York
Author: “Spotlight on Inflammatory Acne”
Skin & Aging, August 2003,
HMP Communications (Publisher)
July 31, 2004
Outstanding Teacher Award
Society of Dermatology Physician Assistants
Las Vegas Local Region
Las Vegas, Nevada
2003
Outstanding Teacher Award
Ohio University College of Osteopathic Medicine
Athens, Ohio
1990
Page 28 of 31
Outstanding Faculty Award Southeast Ohio Region
Ohio University College of Osteopathic Medicine
Athens, Ohio
1989
Edmund D Lowney MD Resident Clinical Instructor Teaching Award
Ohio State University Section of Dermatology
Columbus, Ohio
1989, 1990
Office of Patient Relations Patient Education Award
Ohio University Osteopathic Medical Center
Athens, Ohio
1989
Daniel C Koprince DO Outstanding Lecture Award
American Osteopathic College of Dermatology
Atlanta, Georgia
1989
JAMES Q. DEL ROSSO, DO, FAOCD
January 4, 2016
JDR/ab
Page 29 of 31
Page 30 of 31
Page 31 of 31